steady state for modified release [Regulatives / Guidelines]

posted by Kelen – Brazil, 2019-09-20 22:04 (1673 d 14:10 ago) – Posting: # 20636
Views: 5,227

I would like to ask help for understand the objetive of the steady state study when you are comparing a MR formulation with a IR formulation. The objective would be compare the effect of the accumulation? Is there any reason to conduct the study only with de highest dose?


Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,658 registered users;
106 visitors (0 registered, 106 guests [including 3 identified bots]).
Forum time: 12:14 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5